Search Results

There are 3151 results for: content related to: Regulatory challenges for new drugs to treat obesity and comorbid metabolic disorders

  1. You have free access to this content
    Low adoption of weight loss medications: A comparison of prescribing patterns of antiobesity pharmacotherapies and SGLT2s

    Obesity

    Volume 24, Issue 9, September 2016, Pages: 1955–1961, Catherine E. Thomas, Elizabeth A. Mauer, Alpana P. Shukla, Samrat Rathi and Louis J. Aronne

    Version of Record online : 29 AUG 2016, DOI: 10.1002/oby.21533

  2. You have free access to this content
    Treatment of obesity: Pharmacotherapy trends in the United States from 1999 to 2010

    Obesity

    Volume 23, Issue 8, August 2015, Pages: 1721–1728, Ying Xia, Christina M.L. Kelton, Jeff J. Guo, Boyang Bian and Pamela C. Heaton

    Version of Record online : 20 JUL 2015, DOI: 10.1002/oby.21136

  3. You have free access to this content
    Current and Investigational Antiobesity Agents and Obesity Therapeutic Treatment Targets

    Obesity Research

    Volume 12, Issue 8, August 2004, Pages: 1197–1211, Dr. Harold E. Bays

    Version of Record online : 6 SEP 2012, DOI: 10.1038/oby.2004.151

  4. Use of Prescription Antiobesity Drugs in the United States

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 33, Issue 12, December 2013, Pages: 1299–1307, Christian Hampp, Elizabeth M. Kang and Vicky Borders-Hemphill

    Version of Record online : 9 SEP 2013, DOI: 10.1002/phar.1342

  5. You have free access to this content
    Rise in antiobesity drug prescribing for children and adolescents in the UK: a population-based study

    British Journal of Clinical Pharmacology

    Volume 68, Issue 6, December 2009, Pages: 844–851, Russell M. Viner, Yingfen Hsia, Antje Neubert and Ian C. K. Wong

    Version of Record online : 2 SEP 2009, DOI: 10.1111/j.1365-2125.2009.03528.x

  6. You have free access to this content
    Psychiatric and Cardiovascular Comorbidities in Patients With Diabetes Mellitus Starting Antiobesity Drugs

    Obesity

    Volume 16, Issue 10, October 2008, Pages: 2331–2335, Marjolein J. Willemen, Aukje K. Mantel-Teeuwisse, Sabine M. Straus, Hubert G. Leufkens and Antoine C. Egberts

    Version of Record online : 6 SEP 2012, DOI: 10.1038/oby.2008.362

  7. Effect of antiobesity medications in patients with type 2 diabetes mellitus

    Diabetes, Obesity and Metabolism

    Volume 11, Issue 7, July 2009, Pages: 641–664, Souzana Choussein, Angeliki A. Makri, Constantinos C. Frangos, Eleni Th. Petridou and Stella S. Daskalopoulou

    Version of Record online : 18 FEB 2009, DOI: 10.1111/j.1463-1326.2008.01026.x

  8. Antiobesity Pharmacotherapy: New Drugs and Emerging Targets

    Clinical Pharmacology & Therapeutics

    Volume 95, Issue 1, January 2014, Pages: 53–66, GW Kim, JE Lin, ES Blomain and SA Waldman

    Version of Record online : 19 DEC 2013, DOI: 10.1038/clpt.2013.204

  9. Neuropsychiatric Adverse Effects of Centrally Acting Antiobesity Drugs

    CNS Neuroscience & Therapeutics

    Volume 17, Issue 5, October 2011, Pages: 490–505, Pradeep J. Nathan, Barry V. O’Neill, Antonella Napolitano and Edward T. Bullmore

    Version of Record online : 7 JUL 2010, DOI: 10.1111/j.1755-5949.2010.00172.x

  10. You have full text access to this OnlineOpen article
    Hypothalamic inflammation: a double-edged sword to nutritional diseases

    Annals of the New York Academy of Sciences

    Volume 1243, Issue 1, December 2011, Pages: E1–E39, Dongsheng Cai and Tiewen Liu

    Version of Record online : 9 FEB 2012, DOI: 10.1111/j.1749-6632.2011.06388.x

  11. Edible Brown Alga Ecklonia cava Derived Phlorotannin-Induced Anti-Adipogenic Activity in Vitro

    Journal of Food Biochemistry

    Volume 39, Issue 1, February 2015, Pages: 1–10, Chang-Suk Kong, Haejin Kim and Youngwan Seo

    Version of Record online : 21 NOV 2014, DOI: 10.1111/jfbc.12093

  12. Central and Peripheral Molecular Targets for Antiobesity Pharmacotherapy

    Clinical Pharmacology & Therapeutics

    Volume 87, Issue 6, June 2010, Pages: 652–662, M A Valentino, J E Lin and S A Waldman

    Version of Record online : 5 MAY 2010, DOI: 10.1038/clpt.2010.57

  13. You have full text access to this OnlineOpen article
    Model-Based Approach to Predict Adherence to Protocol During Antiobesity Trials

    The Journal of Clinical Pharmacology

    Vishnu D. Sharma, François P. Combes, Majid Vakilynejad, Gezim Lahu, Lawrence J. Lesko and Mirjam N. Trame

    Version of Record online : 31 AUG 2017, DOI: 10.1002/jcph.994

  14. You have free access to this content
    Effects of a Novel Y5 Antagonist in Obese Mice: Combination With Food Restriction or Sibutramine

    Obesity

    Volume 16, Issue 7, July 2008, Pages: 1510–1515, Satoshi Mashiko, Akane Ishihara, Hisashi Iwaasa, Ryuichi Moriya, Hidefumi Kitazawa, Yuko Mitobe, Junko Ito, Akira Gomori, Hiroko Matsushita, Toshiyuki Takahashi, Douglas J. MacNeil, Lex H.T. Van der Ploeg, Takehiro Fukami and Akio Kanatani

    Version of Record online : 6 SEP 2012, DOI: 10.1038/oby.2008.223

  15. You have free access to this content
    Drug treatment in obesity

    Practical Diabetes International

    Volume 19, Issue 1, January/February 2002, Pages: 25–27, John K. Wales

    Version of Record online : 25 MAR 2002, DOI: 10.1002/pdi.309

  16. Antiobesity Pharmacotherapy: Current Treatment Options and Future Perspectives

    Standard Article

    Handbook of Contemporary Neuropharmacology

    Yuguang Shi

    Published Online : 2 MAR 2007, DOI: 10.1002/9780470101001.hcn073

  17. You have free access to this content
    β-Agonists as Antiobesity, Antidiabetic and Nutrient Partitioning Agents

    Obesity Research

    Volume 3, Issue S4, November 1995, Pages: 531S–536S, Dr. Terence T. Yen

    Version of Record online : 6 SEP 2012, DOI: 10.1002/j.1550-8528.1995.tb00223.x

  18. Antiobesity Effect of Allenic Carotenoid, Fucoxanthin

    Nutrigenomics and Proteomics in Health and Disease: Food Factors and Gene Interactions

    Kazuo Miyashita, Masashi Hosokawa, Pages: 145–160, 2009

    Published Online : 12 JUN 2009, DOI: 10.1002/9780813807263.ch11

  19. Role of taurine in the pathogenesis of obesity

    Molecular Nutrition & Food Research

    Volume 59, Issue 7, July 2015, Pages: 1353–1363, Shigeru Murakami

    Version of Record online : 28 APR 2015, DOI: 10.1002/mnfr.201500067

  20. New Drug Targets for the Treatment of Obesity

    Clinical Pharmacology & Therapeutics

    Volume 90, Issue 1, July 2011, Pages: 40–51, AG Powell, CM Apovian and LJ Aronne

    Version of Record online : 8 JUN 2011, DOI: 10.1038/clpt.2011.82